Pancreatic Cancer Research

ResearcherVirginia–Maryland College of Veterinary MedicineNo recent work listed

Margaret A. Nagai-Singer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6687-6476; OpenAlex author ID A5042325647. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 1 paper

Papers 4

  1. NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. Co-author DOI 10.3389/fonc.2023.1155831↗
  2. Employing Novel Porcine Models of Subcutaneous Pancreatic Cancer to Evaluate Oncological Therapies. First author DOI 10.1007/978-1-0716-1811-0_47↗
  3. Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. First author DOI 10.3389/fonc.2022.853779↗
  4. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Co-author DOI 10.1038/s41598-021-87228-5↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Irving C Allen · 4 shared papers, 2021–2023 · strength 0.68
  2. Khan Mohammad Imran · 2 shared papers, 2022–2023 · strength 0.39
  3. Alissa Hendricks-Wenger · 2 shared papers, 2021–2022 · strength 0.29
  4. Rafael V. Davalos · 2 shared papers, 2021–2022 · strength 0.29
  5. Natalie Beitel-White · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.